Neurogene shareholders elect both director nominees and approve advisory votes at 2024 annual meeting

Neurogene Inc.

Cory Freedland and Rachel McMinn elected as Class I directors with ~9.2M votes for each.
Advisory say-on-pay approved: 9,092,990 for, 482,023 against, 5,878 abstain.
Ratification of Deloitte & Touche as auditor for FY2024 passed with 9,826,384 votes for.
Quorum achieved with 9,829,572 shares (76.4% of voting power) present at June 14, 2024 meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.